Research Platform Myelofibrosis and Anemia

Sponsor
iOMEDICO AG
Study ID
NCT06976918
Status
Recruiting
Apply to this trial

Conditions

  • Anemia
  • Myelofibrosis
  • Myelofibrosis; Anemia
  • Post-essential Thrombocythemia Myelofibrosis
  • Post-polycythemia Vera Myelofibrosis
  • Primary Myelofibrosis
  • Secondary Myelofibrosis

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The purpose of the project is to set up a national, prospective, longitudinal, multicenter cohort study, a tumor research platform, to document uniform data on characteristics, molecular diagnostics, treatment and course of disease and to collect patient-reported outcomes for patients with primary and secondary myelofibrosis and anemia in Germany.

Key Dates

First listed
May 16, 2025
Start date
Feb 19, 2026
Status verified
Mar 2026
Primary completion
Sep 30, 2031
Completion
Sep 30, 2031

Study Design

Enrollment
200 participants (estimated)

Primary Outcome Measure

Documentation of systemic treatment for MF and therapy sequences [ Time Frame: 3 years per patient ]

Central Contacts

Related Studies